Zdrowie i gospodarka · 18/05/2023
FDA Announces Draft Guidance for Ethinyl Estradiol; Segesterone Acetate
The FDA is releasing a draft guidance document outlining product-specific recommendations for the development of ethinyl estradiol; segesterone acetate vaginal ring, which will inform the design of bioequivalence studies for abbreviated new drug applications.
Source: Federal Register — Food and Drug AdministrationOpen original release →